Dynamic Susceptibility Contrast-Enhanced MR Perfusion Imaging in Assessing Recurrent Glioblastoma Response to Superselective Intra-Arterial Bevacizumab Therapy

BACKGROUND AND PURPOSE: Recurrent glioblastoma currently has no established standard of care. We evaluated the response of recurrent glioblastoma to superselective intra-arterial cerebral infusion of bevacizumab by using dynamic susceptibility contrast-enhanced MR perfusion imaging. We hypothesized...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:AJNR Am J Neuroradiol
Egile Nagusiak: Singh, R., Kesavabhotla, K., Kishore, S.A., Zhou, Z., Tsiouris, A.J., Filippi, C.G., Boockvar, J.A., Kovanlikaya, I.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Neuroradiology 2016
Gaiak:
Adult Brain
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5124417/
https://ncbi.nlm.nih.gov/pubmed/27231225
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3174/ajnr.A4823
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak